ScholarIQanswers from OpenAlex & ORCID
Edward A. Stadtmauer
ResearcherPublications, citations & collaboration network
Edward A. Stadtmauer is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Edward A. Stadtmauer have?
ScholarIQindexed works
Edward A. Stadtmauer has 627 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Edward A. Stadtmauer have?
ScholarIQcitation count
Edward A. Stadtmauer has 36,682 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Edward A. Stadtmauer?
ScholarIQh-index
Edward A. Stadtmauer has an h-index of 90 in OpenAlex.
What is the i10-index of Edward A. Stadtmauer?
ScholarIQi10-index
Edward A. Stadtmauer has an i10-index of 268 in OpenAlex.
What is the ORCID of Edward A. Stadtmauer?
ScholarIQorcid
The ORCID for Edward A. Stadtmauer is on the source record.
What is the OpenAlex record for Edward A. Stadtmauer?
ScholarIQopenalex
The OpenAlex for Edward A. Stadtmauer is on the source record.
What are the most-cited papers on Edward A. Stadtmauer?
ScholarIQmost cited works
NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport, Edward A. Stadtmauer, Gwendolyn Binder-Scholl, Olga Goloubeva, Dan T. Vogl, Simon F. Lacey, Ashraf Badros, Alfred L. Garfall, Brendan M. Weiss, Jeffrey Finklestein, Irina Kulikovskaya, Sanjoy K. Sinha, Shari S. Kronsberg, Minnal Gupta, Sarah Bond, Luca Melchiori, Joanna E. Brewer, Alan Bennett, Andrew B. Gerry, Nicholas J. Pumphrey, Daniel Williams, Helen K Tayton- Martin, Lilliam Ribeiro, Tom Holdich, Saul Yanovich, Nancy M. Hardy, Jean A. Yared, Naseem Kerr, Sunita Philip, Sandra Westphal, Don L. Siegel, Bruce L. Levine, Bent K. Jakobsen, Michael Kalos, Carl H. June
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
Adam D. Cohen, Alfred L. Garfall, Edward A. Stadtmauer, J. Joseph Melenhorst, Simon F. Lacey, Eric Lancaster, Dan T. Vogl, Brendan M. Weiss, Karen Dengel, Annemarie Nelson, Gabriela Plesa, Fang Chen, Megan M. Davis, Wei‐Ting Hwang, Regina M. Young, Jennifer L. Brogdon, Randi Isaacs, Iulian Pruteanu-Malinici, Don L. Siegel, Bruce L. Levine, Carl H. June, Michael C. Milone
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
Alfred L. Garfall, Marcela V. Maus, Wei‐Ting Hwang, Simon F. Lacey, Yolanda D. Mahnke, J. Joseph Melenhorst, Zhaohui Zheng, Dan T. Vogl, Adam D. Cohen, Brendan M. Weiss, Karen Dengel, Naseem Kerr, Adam Bagg, Bruce L. Levine, Carl H. June, Edward A. Stadtmauer
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
John R. Wingard, Shelly L. Carter, Thomas J. Walsh, Joanne Kurtzberg, Trudy N. Small, Lindsey R. Baden, Iris D. Gersten, Adam Mendizabal, Helen Leather, Dennis L. Confer, Richard T. Maziarz, Edward A. Stadtmauer, Javier Bolaños‐Meade, J. Martin Brown, John F. DiPersio, Michael Boeckh, Kieren A. Marr
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial
Edward A. Stadtmauer, Marcelo C. Pasquini, Beth Blackwell, Parameswaran Hari, Asad Bashey, Steven M. Devine, Yvonne A. Efebera, S. Ganguly, Cristina Gasparetto, Nancy L. Geller, Mary M. Horowitz, John Koreth, Kristin Knust, Heather Landau, Claudio G. Brunstein, Philip L. McCarthy, Courtney Nelson, Muzaffar H. Qazilbash, Nina Shah, David H. Vesole, Ravi Vij, Dan T. Vogl, Sergio Giralt, George Somlo, Amrita Krishnan